FIBROSIS
Clinical trials for FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS trials appear
Sign up with your email to follow new studies for FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can common drugs stop radiation side effects? new trial aims to find out
Disease control Recruiting nowThis study tests whether two different drug combinations—pentoxifylline with vitamin E, or pravastatin alone—can prevent or reduce lymphedema (swelling) and fibrosis (scarring) caused by radiation therapy for head and neck cancer. About 295 adults who are about to receive radiati…
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:22 UTC
-
New hope for cancer survivors: drug trial targets radiation damage
Disease control Recruiting nowThis study tests if adding medication can treat or prevent lymphedema and fibrosis—painful swelling and scarring—caused by radiation therapy in head and neck cancer survivors. About 250 participants who have finished radiation at least 6 months ago will receive one of several dru…
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Could copper be the key to better liver health in cirrhosis?
Disease control Recruiting nowThis study looks at whether giving copper supplements to people with cirrhosis (scarring of the liver) who have low copper levels can improve liver function and overall health. About 30 adults with cirrhosis and low or borderline copper will take copper or a placebo for a set tim…
Matched conditions: FIBROSIS
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New combo therapy for lung scarring and high blood pressure under study
Disease control Recruiting nowThis study tests a new inhaled drug, mosliciguat, added to an existing treatment (treprostinil) for people with high blood pressure in the lungs caused by scarring lung disease. About 20 adults will take part to see if the combination is safe and tolerable. The goal is to manage …
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Spa treatment may ease radiation skin damage in cancer survivors
Symptom relief Recruiting nowThis study tests whether a special spa therapy can improve skin-related quality of life in people who have skin hardening (fibrosis) after radiation for breast or head/neck cancer. About 110 adults who finished radiation at least 6 months ago will be randomly assigned to get spa …
Matched conditions: FIBROSIS
Phase: NA • Sponsor: Association Francaise pour la Recherche Thermale • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Scientists investigate Diaphragm's role in breathlessness
Knowledge-focused Recruiting nowThis study looks at how well the diaphragm works in 800 people with lung diseases like asthma, COPD, fibrosis, or pulmonary hypertension. Researchers want to understand if diaphragm problems are linked to shortness of breath. No new treatments are being tested—this is an observat…
Matched conditions: FIBROSIS
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC
-
HIV drug showdown: which is safer for your liver?
Knowledge-focused Recruiting nowThis study aims to find out if two types of HIV medications (NNRTI and INSTI) cause different levels of fatty liver disease in people with HIV. Researchers will screen 200 HIV patients using ultrasound to measure liver fat and stiffness. The goal is to learn which drug class may …
Matched conditions: FIBROSIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC